(Q80402867)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286768%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Urgently needed: a filter for the HIV-1 vaccine pipeline (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286768%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

Dennis R Burton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286768%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

John P Moore

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286768%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286768%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286768%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286768%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

769-771

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286768%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286768%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm0804-769

31 December 2019

exact match

0 references

cites work

Immunopathogenesis and immunotherapy in AIDS virus infections

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

HIV vaccine design and the neutralizing antibody problem

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Length distribution of CDRH3 in antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

The antiviral activity of antibodies in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Occupancy and mechanism in antibody-mediated neutralization of animal viruses

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Primary isolate neutralization by HIV type 1-infected patient sera in the era of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

A luciferase-reporter gene-expressing T-cell line facilitates neutralization and drug-sensitivity assays that use either R5 or X4 strains of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Medicine. The need for a global HIV vaccine enterprise

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4.

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-769

7 January 2021

Identifiers

DOI

10.1038/NM0804-769

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286768%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference